Search alternatives:
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
ann decrease » nn decrease (Expand Search), a decrease (Expand Search), gain decreased (Expand Search)
via large » a large (Expand Search)
_ ann » _ any (Expand Search), _ anc (Expand Search)
Showing 1 - 20 results of 2,997 for search '(( via large decrease ) OR ((( _ large decrease ) OR ( _ ann decrease ))))', query time: 0.45s Refine Results
  1. 1
    ANN architecture.

    ANN architecture. by Abdelfattah Dani (22226715)

    Published 2025
    Save to List
    Saved in:
  2. 2
    ANN architecture and configuration.

    ANN architecture and configuration. by Abdelfattah Dani (22226715)

    Published 2025
    Save to List
    Saved in:
  3. 3
    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles

    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles

    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles

    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles

    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles

    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles

    High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Illustration of BSC control using ANN for WECS.

    Illustration of BSC control using ANN for WECS. by Abdelfattah Dani (22226715)

    Published 2025
    Save to List
    Saved in:
  10. 10
    Continuous Viscoelasticity Measurement of Cell Spheroids via Microfluidic Electrical Aspiration

    Continuous Viscoelasticity Measurement of Cell Spheroids via Microfluidic Electrical Aspiration by Heyi Chen (19930197)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 11
    Performance comparison between the OTC-FOC and ANN-BSC.

    Performance comparison between the OTC-FOC and ANN-BSC. by Abdelfattah Dani (22226715)

    Published 2025
    Save to List
    Saved in:
  12. 12
    Training process flowchart of ANN-based MPPT controller.

    Training process flowchart of ANN-based MPPT controller. by Abdelfattah Dani (22226715)

    Published 2025
    Save to List
    Saved in:
  13. 13
    THD for the stator current i<sub>sb</sub> (ANN-BSC).

    THD for the stator current i<sub>sb</sub> (ANN-BSC). by Abdelfattah Dani (22226715)

    Published 2025
    Save to List
    Saved in:
  14. 14
    ANN-BSC outcomes: (a) PMSG currents, (b) Zoom-in illustration.

    ANN-BSC outcomes: (a) PMSG currents, (b) Zoom-in illustration. by Abdelfattah Dani (22226715)

    Published 2025
    Save to List
    Saved in:
  15. 15
    Penalty conversions yield large practical decreases, but robustness and generalizability of result are limited by data quality and sample selection.

    Penalty conversions yield large practical decreases, but robustness and generalizability of result are limited by data quality and sample selection. by Ryan J. Treves (13527735)

    Published 2025
    Save to List
    Saved in:
  16. 16
    Baseline patient characteristics across neutralizing monoclonal antibody trials.

    Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: